FDA label ea1daf4e-58fc-4184-bc79-9582785084b7

openFDA label record#

This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.

Verified complete openFDA source JSON (canonical bytes are SHA-256 checked before publication)

SPL set ID
8a2f32ae-cbb7-4fc0-e053-2995a90ab374
SPL ID
ea1daf4e-58fc-4184-bc79-9582785084b7
Version
6
Effective date
2024-06-10
Source export date
2026-10-30
Source partition
5
Source file
https://download.open.fda.gov/drug/label/drug-label-0005-of-0014.json.zip
Source object key
raw/openfda/drug-label/2026-10-30/a900515c00f4d0d29f88cc94ee68daf127f036296f87a6b4a8a3f964cd0433c0/drug-label-0005-of-0014.json.zip
Source manifest SHA-256
b11f1f6b476c7417db937215bf14307ef1a0b69465b42b411ad52f42ae36ead3
Import run
20261102T182004Z
Imported at
2026-11-02 18:45:27

Warnings cross-check#

openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.

Warnings sections page 1 of 1 · 1 matching rows.

warnings

Warning Don't use if allergic to urea or any other ingredients in Uremol. Avoid contact with eyes and mucous membrane; in case of contact, wash with water. After application, if you may notice rash, itchiness, irritation, pain, reddening, burning or discoloration of the skin, consult a healthcare practitioner. If too much is applied, irritation may occur. If irritation worsens or persists, discontinue temporarily. Consult a health care professional: if you are pregnant or breastfeeding, if symtoms worsen or last for more than 7 days or if using other topical product on your skin or for use beyond 1 month.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.